Positive Fibrin Test in Peritoneal Dialysis Effluent
A positive fibrin test in peritoneal dialysis effluent indicates active intraperitoneal coagulation and fibrin formation, which occurs both during normal PD therapy and is markedly elevated during peritonitis, serving as a marker of peritoneal inflammation and potential membrane dysfunction.
Clinical Significance
Normal PD State (Without Peritonitis)
- Baseline fibrin formation occurs continuously in all PD patients, even when clinically stable, reflecting ongoing thrombin-induced intraperitoneal fibrin generation during regular dialysis exchanges 1
- Fibrin monomer levels reach approximately 24.5 ± 7.1 micrograms/mL after a 4-hour dwell in stable patients, with concentrations increasing progressively throughout the dwell time 1
- The dialysate-to-plasma ratios of fibrin-related antigens are significantly higher than expected from simple plasma diffusion, confirming local intraperitoneal production rather than systemic origin 1
- This represents a high rate of intraperitoneal fibrin turnover that is balanced by concurrent fibrinolysis under normal conditions 1, 2
During Peritonitis
- Fibrin levels increase dramatically during bacterial peritonitis, with fibrin monomer concentrations reaching 972 ± 3.2 micrograms/mL (approximately 40-fold higher than baseline) 1
- The ratio between fibrin monomer and fibrin degradation products increases 2.4-times during peritonitis, indicating an imbalance where coagulation exceeds fibrinolysis 1
- This imbalance reflects disturbed peritoneal hemostasis with excessive fibrin deposition that may contribute to peritoneal membrane damage 2
- Fibrin degradation products (FDPs) also increase significantly during peritonitis (16.4 ± 2.9 micrograms/L versus 1.0 ± 0.3 micrograms/L in stable patients) 1
Diagnostic Interpretation Algorithm
Step 1: Assess Clinical Context
- If patient has cloudy effluent, abdominal pain, or fever: Positive fibrin test supports peritonitis diagnosis but must be confirmed with white cell count >100 cells/μL and culture 3
- If patient is clinically stable: Positive fibrin test represents normal baseline fibrin turnover and does not indicate pathology 1
Step 2: Timing Considerations
- Never interpret fibrin tests during or within 1 month after peritonitis resolution, as peritonitis transiently alters all peritoneal transport characteristics and produces falsely abnormal findings 4, 5
- Wait at least 4 weeks after peritonitis resolution before obtaining any peritoneal membrane function tests 4
Step 3: Correlation with Other Markers
- Elevated fibrin should be interpreted alongside IL-6 and FDP levels, which correlate positively with each other and reflect chronic peritoneal inflammation 6
- The combination of elevated IL-6 and FDPs correlates with increased permeability to large molecules (albumin, α2-macroglobulin), indicating progressive peritoneal membrane deterioration 6
- Serial measurements showing increasing fibrin/FDP levels over time predict peritoneal deterioration and potential development of encapsulating peritoneal sclerosis 6
Clinical Implications
For Acute Management
- Positive fibrin test with clinical peritonitis symptoms warrants immediate antibiotic therapy plus intraperitoneal heparin administration 2
- Heparin treatment significantly reduces fibrin monomer, TAT, and F1+2 levels within 7 days of peritonitis treatment 2
For Long-Term Monitoring
- Longitudinal tracking of fibrin-related markers helps predict peritoneal membrane failure, particularly when combined with IL-6 and FDP measurements 6
- Progressive increases in fibrin markers correlate with increased D/P ratios for large molecules (albumin, α2-macroglobulin) but not necessarily with D/P creatinine from standard PET testing 6
- This dissociation means standard peritoneal equilibration tests may miss early peritoneal deterioration that fibrin markers can detect 6
Critical Pitfalls to Avoid
- Do not confuse fibrin in effluent with simple cloudy dialysate: Cloudy effluent has multiple causes including leukocytes, eosinophils, red blood cells, chyle, or even malignant cells 7
- Do not obtain fibrin measurements during acute illness or recent peritonitis: Results will be transiently elevated and non-interpretable for baseline membrane function 4
- Do not rely solely on D/P creatinine to assess peritoneal membrane health: Fibrin-related markers and large molecule permeability provide complementary information about membrane deterioration not captured by standard PET 6
- Do not ignore progressively rising fibrin markers in stable patients: This may indicate subclinical chronic inflammation leading to ultrafiltration failure and eventual technique failure 6